C16orf82
gene geneOn this page
Also known as TNT
Summary
C16orf82 (chromosome 16 open reading frame 82, HGNC:30755) is a protein-coding gene on chromosome 16p12.1, encoding Protein TNT (Q7Z2V1).
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_001145545
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30755 |
| Approved symbol | C16orf82 |
| Name | chromosome 16 open reading frame 82 |
| Location | 16p12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TNT |
| Ensembl gene | ENSG00000234186 |
| Ensembl biotype | protein_coding |
| Entrez | 162083 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000505035
RefSeq mRNA: 1 — MANE Select: NM_001145545
NM_001145545
Canonical transcript exons
ENST00000505035 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002066194 | 27066927 | 27069166 |
Expression profiles
Bgee: expression breadth broad, 62 present calls, max score 98.09.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8030 / max 811.0508, expressed in 14 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 153291 | 0.4324 | 6 |
| 153292 | 0.3340 | 8 |
| 153290 | 0.0316 | 3 |
| 153293 | 0.0050 | 1 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.09 | gold quality |
| right testis | UBERON:0004534 | 97.87 | gold quality |
| sperm | CL:0000019 | 97.45 | gold quality |
| testis | UBERON:0000473 | 95.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.38 | gold quality |
| adult organism | UBERON:0007023 | 87.38 | gold quality |
| pancreatic ductal cell | CL:0002079 | 76.53 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 76.47 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.65 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 73.68 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 73.52 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 69.17 | gold quality |
| upper arm skin | UBERON:0004263 | 68.84 | gold quality |
| kidney epithelium | UBERON:0004819 | 67.88 | gold quality |
| myocardium | UBERON:0002349 | 65.87 | gold quality |
| vastus lateralis | UBERON:0001379 | 62.58 | gold quality |
| quadriceps femoris | UBERON:0001377 | 62.44 | gold quality |
| gingival epithelium | UBERON:0001949 | 62.10 | gold quality |
| deltoid | UBERON:0001476 | 61.54 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 61.53 | gold quality |
| vena cava | UBERON:0004087 | 61.45 | gold quality |
| ileal mucosa | UBERON:0000331 | 60.87 | silver quality |
| cauda epididymis | UBERON:0004360 | 60.84 | gold quality |
| gingiva | UBERON:0001828 | 59.44 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 59.38 | gold quality |
| superficial temporal artery | UBERON:0001614 | 58.40 | gold quality |
| tibialis anterior | UBERON:0001385 | 58.25 | silver quality |
| biceps brachii | UBERON:0001507 | 57.50 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 57.10 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 56.35 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 32.68 |
| E-ANND-3 | no | 1.48 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
67 targeting C16orf82, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-187-5P | 99.74 | 70.26 | 1404 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-6762-3P | 99.66 | 66.94 | 1188 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-7112-5P | 99.59 | 65.76 | 104 |
| HSA-MIR-182-3P | 99.57 | 67.57 | 825 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-19A-5P | 99.36 | 66.93 | 1675 |
| HSA-MIR-19B-1-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-19B-2-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-3064-5P | 99.26 | 66.13 | 1497 |
| HSA-MIR-3085-3P | 99.26 | 66.16 | 1490 |
| HSA-MIR-6504-5P | 99.26 | 65.95 | 1487 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Protein TNT — Q7Z2V1 (reviewed: Q7Z2V1)
All UniProt accessions (1): A0A5F9ZHF3
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Preferentially expressed in teratocarcinoma rather than in normal testis.
RefSeq proteins (1): NP_001139017* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031520 | DUF4694 | Family |
Pfam: PF15765
UniProt features (8 total): compositionally biased region 6, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z2V1-F1 | 57.55 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
chr16p12, MIR651_3P, MIR5701, MIR5089_5P, MIR6762_3P, MIR380_5P, GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN, HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL, GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
36 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C16orf82 | ETHE1 | O95571 | 348 |
| C16orf82 | ACTN2 | P35609 | 322 |
| C16orf82 | LYSMD3 | Q7Z3D4 | 320 |
| C16orf82 | SCAF8 | Q9UPN6 | 271 |
| C16orf82 | TIMM10B | Q9Y5J6 | 270 |
| C16orf82 | TNNT1 | P13805 | 269 |
| C16orf82 | APIP | Q96GX9 | 232 |
| C16orf82 | TIMM10 | P62072 | 217 |
| C16orf82 | SDF4 | Q9BRK5 | 207 |
| C16orf82 | CITED4 | Q96RK1 | 194 |
| C16orf82 | UBE2H | P37286 | 191 |
| C16orf82 | CLK4 | Q9HAZ1 | 183 |
| C16orf82 | MYF5 | P13349 | 166 |
| C16orf82 | MYOD1 | P15172 | 164 |
| C16orf82 | CDC14A | Q9UNH5 | 162 |
IntAct
0 interactions, top by confidence:
BioGRID (1): C16orf82 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0JNH1, A6NCI8, A6NGY1, A6NKB5, A6X8Z5, D3Z1D3, E9Q0C6, E9Q286, E9Q3S4, E9Q7D5, M0RD54, O14513, O88466, O94854, P46013, Q05860, Q0VAV2, Q0VF49, Q12774, Q1RMX6, Q2M3C7, Q32LI3, Q3MHH3, Q3MJ40, Q3URK3, Q3V0A6, Q49AJ0, Q4V7J0, Q5DU28, Q5F2C3, Q5VV67, Q66H53, Q68DA7, Q6NZN1, Q711Q0, Q7TSG5, Q7Z2V1, Q80VY2, Q80W69, Q86TB3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1012 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000118879 (16:27067912 A>G), RS1000446759 (16:27069189 C>T), RS1002062646 (16:27068665 C>T), RS1003415294 (16:27066846 A>C), RS1003679959 (16:27067865 C>T), RS1005015688 (16:27069625 T>C), RS1006306670 (16:27066222 C>A,G), RS1006687320 (16:27066374 C>T), RS1007534416 (16:27067923 T>C), RS1008225665 (16:27068997 C>T), RS1008672921 (16:27068801 C>T), RS1008975478 (16:27067896 A>G), RS1009149736 (16:27068696 C>T), RS1009732816 (16:27069334 C>T), RS1010100962 (16:27067964 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002701_1 | Verbal declarative memory | 3.000000e-08 |
| GCST002701_16 | Verbal declarative memory | 1.000000e-07 |
| GCST004311_1 | Facial morphology (factor 7, width of cartilaginous portion of nose) | 2.000000e-08 |
| GCST006427_52 | Depression in smokers | 5.000000e-06 |
| GCST008152_155 | Weight | 6.000000e-06 |
| GCST008157_21 | Body fat mass | 8.000000e-06 |
| GCST009391_787 | Metabolite levels | 4.000000e-07 |
| GCST009798_67 | Asthma | 5.000000e-11 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0006805 | word list delayed recall measurement |
| EFO:0004338 | body weight |
| EFO:0010395 | sphingomyelin 22:0 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.